Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Feigenberg

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Breast Cancer Research and Treatment|February 24, 2019
Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysisStephanie R Rice, Steven J Feigenberg, Muhammad Hamza, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2010
Rectal dose variation during the course of image-guided radiation therapy of prostate cancerLili Chen, Kamen Paskalev, Xiu Xu, et al.
Lancet (London, England)|January 19, 2025
Radiotherapy toxicities: mechanisms, management, and future directionsIoannis I Verginadis, Deborah E Citrin, Bonnie Ky, et al.
Annals of Surgical Oncology|August 3, 2017
Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer DatabaseLindsay K Hessler, Jason K Molitoris, Paula Y Rosenblatt, et al.
The Oncologist|May 24, 2017
Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality TherapyKatherine A Scilla, Søren M Bentzen, Vincent K Lam, et al.
Academic Radiology|January 27, 2025
Prediction of Radiation Therapy Induced Cardiovascular Toxicity from Pretreatment CT Images in Patients with Thoracic Malignancy via an Optimal Biomarker ApproachMujun Long, Mostafa Alnoury, Jayaram K Udupa, et al.
Advances in Radiation Oncology|October 21, 2020
Higher Dose Volumes May Be Better for Evaluating Radiation Pneumonitis in Lung Proton Therapy Patients Compared With Traditional Photon-Based Dose ConstraintsWendy B Harris, Wei Zou, Chingyun Cheng, et al.
American Journal of Clinical Oncology|November 11, 2010
Increased recurrences using intensity-modulated radiation therapy in the postoperative settingAruna Turaka, Tianyu Li, Navesh K Sharma, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2010
Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancerKyle E Rusthoven, Steven J Feigenberg, David Raben, et al.
JAMA Oncology|February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSalma K Jabbour, Abigail T Berman, Roy H Decker, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|February 24, 2019
Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysisStephanie R Rice, Steven J Feigenberg, Muhammad Hamza, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2010
Rectal dose variation during the course of image-guided radiation therapy of prostate cancerLili Chen, Kamen Paskalev, Xiu Xu, et al.
Lancet (London, England)|January 19, 2025
Radiotherapy toxicities: mechanisms, management, and future directionsIoannis I Verginadis, Deborah E Citrin, Bonnie Ky, et al.
Annals of Surgical Oncology|August 3, 2017
Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer DatabaseLindsay K Hessler, Jason K Molitoris, Paula Y Rosenblatt, et al.
The Oncologist|May 24, 2017
Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality TherapyKatherine A Scilla, Søren M Bentzen, Vincent K Lam, et al.
Academic Radiology|January 27, 2025
Prediction of Radiation Therapy Induced Cardiovascular Toxicity from Pretreatment CT Images in Patients with Thoracic Malignancy via an Optimal Biomarker ApproachMujun Long, Mostafa Alnoury, Jayaram K Udupa, et al.
Advances in Radiation Oncology|October 21, 2020
Higher Dose Volumes May Be Better for Evaluating Radiation Pneumonitis in Lung Proton Therapy Patients Compared With Traditional Photon-Based Dose ConstraintsWendy B Harris, Wei Zou, Chingyun Cheng, et al.
American Journal of Clinical Oncology|November 11, 2010
Increased recurrences using intensity-modulated radiation therapy in the postoperative settingAruna Turaka, Tianyu Li, Navesh K Sharma, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2010
Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancerKyle E Rusthoven, Steven J Feigenberg, David Raben, et al.
JAMA Oncology|February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSalma K Jabbour, Abigail T Berman, Roy H Decker, et al.
Pageof 12